Cargando…
Combining Immunotherapy with Oncogene-Targeted Therapy: A New Road for Melanoma Treatment
Cutaneous melanoma arises from the malignant transformation of skin melanocytes; its incidence and mortality have been increasing steadily over the last 50 years, now representing 3% of total tumors. Once melanoma metastasizes, prognosis is somber and therapeutic options are limited. However, the di...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4321613/ https://www.ncbi.nlm.nih.gov/pubmed/25709607 http://dx.doi.org/10.3389/fimmu.2015.00046 |